Epimorphic regeneration in mice is p53-independent

Cell Cycle

Volumn 9, Issue 18, 2010, Pages 3691-3697

  Arthur, L Matthew ^a   Demarest, Renee M ^a   Clark, Lise ^a   Gourevitch, Dmitri ^a   Bedelbaeva, Kamila ^a   Anderson, Rhonda ^a   Snyder, Andrew ^b   Capobianco, Anthony J ^c   Lieberman, Paul ^a   Feigenbaum, Lionel ^a   Heber Katz, E ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b TargAnox Inc   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Ear hole; Mouse; MRL; p21; p53; Regeneration; Tgf

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; PROTEIN P16; PROTEIN P21; PROTEIN P53; RAG2 PROTEIN; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ADIPOCYTE; APOPTOSIS; BACKCROSSING; CARTILAGE CELL; CELL ACTIVITY; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL REGENERATION; CHONDROGENESIS; DNA DAMAGE; EAR; GENE MUTATION; HISTOLOGY; NONHUMAN; PHENOTYPE; PROTEIN DEPLETION; REVIEW; SENESCENCE; TISSUE DIFFERENTIATION; TISSUE REGENERATION; UPREGULATION; WOUND HEALING;

AMBYSTOMA MEXICANUM; HYDRA; MAMMALIA; MUS; PLANARIA; SALAMANDRIDAE; SALAMANDROIDEA;

EID: 77956994822     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.9.18.13119     Document Type: Review

References (75)

1. Rao N, Jhamb D, Milner D, Li B, Song F, Wang M, et al. Proteomic analysis of blastema formation in regenerating axolotl limbs. BMC Biology 2009; 7:83.
2. Stocum DL. The urodele limb regeneration blastema. Determination and organization of the morphogenetic field. Differentiation 1984; 27:55-7.
3. Carlson BM. Some principles of regeneration in mammalian systems. In 2010; 4-13.
4. Kragl M, Knapp D, Nacu E, Khattak S, Maden M, Epperlein HH, et al. Cells keep a memory of their tissue origin during axolotl limb regeneration. Nature 2009; 460:60-5.
5. Kierdorf U, Kierdorf H. Deer Antlers-A Model of Mammalian Appendage Regeneration: An Extensive Review. Gerontology 2010; [Epub ahead of print].
6. ten Koppel PGJ, van Osch GJVM, Verwoerd CDA, Verwoerd-Verhoef HL. A new in vivo model for testing cartilage grafts and biomaterials: the 'rabbit pinna punch-hole' model. Biomaterials 2001; 22:1407-14.
7. Clark LD, Clark RK, Heber-Katz E. A New Murine Model for Mammalian Wound Repair and Regeneration. Clinical Immunology and Immunopathology 1998; 88:35-45. (Pubitemid 28360931)
8. Gourevitch D, Clark L, Chen P, Seitz A, Samulewicz SJ, Heber-Katz E. Matrix metalloproteinase activity correlates with blastema formation in the regenerating MRL mouse ear hole model. Developmental Dynamics 2003; 226:377-87. (Pubitemid 36158182)
9. Bedelbaeva K, Snyder A, Gourevitch D, Clark L, Zhang XM, Leferovich J, et al. Lack of p21 expression links cell cycle control and appendage regeneration in mice. Proceedings of the National Academy of Sciences 2010; 107:5845-50.
10. El Deiry WS. p21/p53, cellular growth control and genomic integrity. Curr Top Microbiol Immunol 1998; 227:121-37.
11. Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 Mutations in Human Cancers. Science 91 A.D. 253:49-53.
12. Vousden KH. p53: Death Star. Cell 2000; 103:691-4.
13. Harper JW, Elledge SJ. The DNA Damage Response: Ten Years After. Molecular Cell 2007; 28:739-45.
14. Vousden KH, Prives C. Blinded by the Light: The Growing Complexity of p53. Cell 2009; 137:413-31.
15. El Deiry WS. Regulation of p53downstream genes. Seminars in Cancer Biology 1998; 8:345-57.
16. Kuribayashi K, El Deiry WS. Regulation of Programmed Cell Death by the p53 Pathway. In 2007; 201-21.
17. Fei P, El Deiry WS. P53 and radiation responses. Oncogene 2003; 22:5774-83.
18. Ruzankina Y, Schoppy DW, Asare A, Clark CE, Vonderheide RH, Brown EJ. Tissue regenerative delays and synthetic lethality in adult mice after combined deletion of Atr and Trp53. Nat Genet 2009; 41:1144-9.
19. Child ES, Mann DJ. The Intricacies of p21 Phosphorylation: Protein/Protein Interactions, Subcellular Localization and Stability. Cell Cycle 2006; 5:1313-9.
20. El Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993; 75:817-25.
21. Jung YS, Qian Y, Chen X. Examination of the expanding pathways for the regulation of p21 expression and activity. Cellular Signalling 2010; 22:1003-12.
22. 2/M Cell Cycle Transitions: pRb Is a Critical Determinant in Blocking DNA Replication and in Preventing Endoreduplication. Mol Cell Biol 1998; 18:629-43.
23. Peng CY, Graves PR, Thoma RS, Wu Z, Shaw AS, Piwnica-Worms H. Mitotic and G2 Checkpoint Control: Regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on Serine-216. Science 1997; 277:1501-5.
24. 2/M checkpoint. Genes & Development 2000; 14:1584-8.
25. Afshari CA, Nichols MA, Xiong Y, Mudryj M. A role for a p21-E2F interaction during senescence arrest of normal human fibroblasts. Cell Growth Differ 1996; 7:979-88. (Pubitemid 26360708)
26. Pantoja C, Serrano M. Murine fibroblasts lacking p21 undergo senescence and are resistant to transformation by oncogenic Ras. Oncogene 1999; 18:4974-82.
27. Wang YA, Elson A, Leder P. Loss of p21 increases sensitivity to ionizing radiation and delays the onset of lymphoma in atm-deficient mice. Proc Natl Acad Sci USA 1997; 94:14590-5.
28. Ozturk M, Arslan-Ergul A, Bagislar S, Senturk S, Yuzugullu H. Senescence and immortality in hepatocellular carcinoma. Cancer Lett 2009; 286:103-13.
29. Dimri GP. What has senescence got to do with cancer? Cancer Cell 2005; 7:505-12.
30. Collado M, Serrano M. Senescence in tumours: evidence from mice and humans. Nat Rev Cancer 2010; 10:51-7.
31. Collado M, Gil J, Efeyan A, Guerra C, Schuhmacher AJ, Barradas M, et al. Tumour biology: senescence in premalignant tumours. Nature 2005; 436:642.
32. Schmitt CA. Cellular senescence and cancer treatment. Biochim Biophys Acta 2007; 1775:5-20.
33. Xue W, Zender L, Miething C, Dickins RA, Hernando E, Krizhanovsky V, et al. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 2007; 445:656-60.
34. Begus-Nahrmann Y, Lechel A, Obenauf AC, Nalapareddy K, Peit E, Hoffmann E, et al. p53 deletion impairs clearance of chromosomal-instable stem cells in aging telomere-dysfunctional mice. Nat Genet 2009; 41:1138-43.
35. Chen Z, Trotman LC, Shaffer D, Lin HK, Dotan ZA, Niki M, et al. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 2005; 436:725-30.
36. Waf1/Cip1/Sdi1 induces permanent growth arrest with markers of replicative senescence in human tumor cells lacking functional p53. Oncogene 1999; 18:2789-97.
37. waf expression in H1299 cell line promotes cell senescence and protects against cytotoxic effect of radiation and doxorubicin. Oncogene 1999; 18:2643-9.
38. Yazinski SA, Westcott PMK, Ong K, Pinkas J, Peters RM, Weiss RS. Dual inactivation of Hus1 and p53 in the mouse mammary gland results in accumulation of damaged cells and impaired tissue regeneration. Proceedings of the National Academy of Sciences 2009; 106:21282-7.
39. Schoppy DW, Ruzankina Y, Brown EJ. Removing all obstacles: A critical role for p53 in promoting tissue renewal. Cell Cycle 2010; 9:1313-9.
40. CIP1/WAF1 Gene in Normal Diploid Human Fibroblasts. Science 1997; 277:831-4.
41. Jacks T, Remington L, Williams BO, Schmitt EM, Halachmi S, Bronson RT, et al. Tumor spectrum analysis in p53-mutant mice. Curr Biol 1994; 4:1-7.
42. Blankenhorn EP, Troutman S, Clark LD, Zhang XM, Chen P, Heber-Katz E. Sexually dimorphic genes regulate healing and regeneration in MRL mice. Mamm Genome 2003; 14:250-60.
43. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA Jr, Butel JS, et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 1992; 356:215-21.
44. 2 without requiring mitosis or S phase. J Cell Biol 1990; 110:939-45.
45. Schmidt T, David CN. Gland cells in Hydra: cell cycle kinetics and development. J Cell Sci 1986; 85:197-215.
46. Chuykin IA, Lianguzova MS, Pospelova TV, Pospelov VA. Activation of DNA damage response signaling in mouse embryonic stem cells. Cell Cycle 2008; 7:2922-8.
47. Salo E, Baguna J. Regeneration and pattern formation in planarians: I. The pattern of mitosis in anterior and posterior regeneration in Dugesia (G) tigrina and a new proposal for blastema formation. J Embryol Exper Morphol 1984; 83:63-80.
48. Tassava RA, Mescher AL. Mitotic activity and nucleic acid precursor incorporation in denervated and innervated limb stumps of axolotl larvae. J Exper Zool 1976; 195:253-62.
49. Van Bezooijen CF, Van Noord MJ, Knook DL. The viability of parenchymal liver cells isolated from young and old rats. Mech Ageing Dev 1974; 2:107-19.
50. Guidotti JE, Bregerie O, Robert A, Debey P, Brechot C, Desdouets C. Liver Cell Polyploidization: A Pivotal Role for Binuclear Hepatocytes. J Biol Chem 2003; 278:19095-101.
51. Gil J, Peters G. Regulation of the INK4b-ARF-INK4a tumour suppressor locus: all for one or one for all. Nat Rev Mol Cell Biol 2006; 7:667-77.
52. 2/M transition by p53. Oncogene 2001; 20:1803-15.
53. Arf predisposes mice to tumorigenesis. Nature 2001; 413:86-91.
54. Hollander MC, Sheikh MS, Bulavin DV, Lundgren K, Augeri-Henmueller L, Shehee R, et al. Genomic instability in Gadd45a-deficient mice. Nat Genet 1999; 23:176-84.
55. Braig M, Lee S, Loddenkemper C, Rudolph C, Peters AH, Schlegelberger B, et al. Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 2005; 436:660-5.
56. Herbig U, Sedivy JM. Regulation of growth arrest in senescence: telomere damage is not the end of the story. Mech Ageing Dev 2006; 127:16-24.
57. Ben Porath I, Weinberg RA. When cells get stressed: an integrative view of cellular senescence. J Clin Invest 2004; 113:8-13.
58. Gartel AL, Radhakrishnan SK. Lost in Transcription: p21 Repression, Mechanisms and Consequences. Cancer Res 2005; 65:3980-5.
59. Jacks T, Fazeli A, Schmitt EM, Bronson RT, Goodell M, Weinberg O. Effects of an Rb mutation in the mouse. Nature 1992; 359:295-300.
60. Moustakas A, Pardali K, Gaal A, Heldin CH. Mechanisms of TGF[beta] signaling in regulation of cell growth and differentiation. Immunology Letters 2002; 82:85-91.
61. Bierie B, Moses HL. Tumour microenvironment: TGF[beta]: the molecular Jekyll and Hyde of cancer. Nat Rev Cancer 2006; 6:506-20.
62. Pardali K, Moustakas A. Actions of TGF[beta] as tumor suppressor and pro-metastatic factor in human cancer. Biochim Biophys Acta 2007; 1775:21-62.
63. Massague J. TGF[beta] in Cancer. Cell 2008; 134:215-30.
64. /WAF1/Cip1 promoter in hepatic cells by functional interactions between Sp1 and Smad family members. Proc Natl Acad Sci USA 1998; 95:6733-8.
65. 2. J Biol Chem 2000; 275:29244-56.
66. Grose R, Werner S. Wound-healing studies in transgenic and knockout mice. Mol Biotechnol 2004; 28:147-66.
67. O'Kane S, Ferguson MWJ. Transforming growth factor [beta]s and wound healing. The International J Biochem Cell Biol 1997; 29:63-78. (Pubitemid 27096420)
68. Crowe MJ, Doetschman T, Greenhalgh DG. Delayed wound healing in immunodeficient TGF[beta]1 knockout mice. J Invest Dermatol 2000; 115:3-11. (Pubitemid 30470184)
69. Ashcroft GS, Yang X, Glick AB, Weinstein M, Letterio JJ, Mizel DE, et al. Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response. Nat Cell Biol 1999; 1:260-6.
70. Arany PR, Flanders KC, Kobayashi T, Kuo CK, Stuelten C, Desai KV, et al. Smad3 deficiency alters key structural elements of the extracellular matrix and mechanotransduction of wound closure. Proc Natl Acad Sci USA 2006; 103:9250-5. (Pubitemid 43902564)
71. Blankenhorn EP, Bryan G, Kossenkov AV, Desquenne Clark L, Zhang X-M, Chang C, et al. Loci that regulate healing and regeneration in LG/J and SW/J mice. Mammalian Genome 2009; 20:720-33
72. Zhong Z, Tsukada S, Rehman H, Parsons CJ, Theruvath TP, Rippe RA, et al. Inhibition of transforming growth factor-beta/Smad signaling improves regeneration of small-for-size rat liver grafts. Liver Transpl 2010; 16:181-90.
73. Engle SJ, Hoying JB, Boivin GP, Ormsby I, Gartside PS, Doetschman T. Transforming growth factor-beta1 suppresses nonmetastatic colon cancer at an early stage of tumorigenesis. Cancer Res 1999; 59:3379-86. (Pubitemid 29334496)
74. Hallenborg P, Feddersen S, Madsen L, Kristiansen K. The tumor suppressors pRB and p53 as regulators of adipocyte differentiation and function. Expert Opin Ther Targets 2009; 13:235-46.
75. Hong H, Takahashi K, Ichisaka T, Aoi T, Kanagawa O, Nakagawa M, et al. Suppression of induced pluripotent stem cell generation by the p53/p21 pathway. Nature 2009; 460:1132-5.